Wie hoch ist der Preis für PharmaBlock Sciences (Nanjing), Inc. (300725)

Preis für PharmaBlock Sciences (Nanjing), Inc. (300725) ist $6.59

Wie hoch ist die Marktkapitalisierung für PharmaBlock Sciences (Nanjing), Inc. (300725)

Marktkapitalisierung für PharmaBlock Sciences (Nanjing), Inc. (300725) ist $1.54B

PharmaBlock Sciences (Nanjing), Inc. (300725) KUV

PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.

Jahr	P/S-Verhältnis	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

P/S-Verhältnis

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	P/S-Verhältnis	P/S-Verhältnis-Differenz	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	-	IN

Unternehmen

P/S-Verhältnis

P/S-Verhältnis-Differenz

Land